Top Losers In Today's Pre-Market Session
- Preliminary Q1 reports EPS $0.17 vs. $0.20 estimate; Chair, President and CEO Michael Barnes resigned
- Received Grand Jury subpoena from Department of Justice; internal control over financial reporting was ineffective
- Revenue $402.1 million vs. $415.1 million estimate
- Outpatient prescription covered down over 200 per week and hospital units sold down over 80 units per week
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.